A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?
In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported. Emphasis is given on recent results about a new...
Saved in:
Main Authors: | Vasiliki D. Papakonstantinou, Nefeli Lagopati, Effie C. Tsilibary, Constantinos A. Demopoulos, Athanassios I. Philippopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-01-01
|
Series: | Bioinorganic Chemistry and Applications |
Online Access: | http://dx.doi.org/10.1155/2017/6947034 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vitamin Bs as Potent Anticancer Agents through MMP-2/9 Regulation
by: Ha Vy Thi Vo, et al.
Published: (2025-01-01) -
Hydroxyl-platelet-activating factor exists in blood of healthy volunteers and periodontal patients
by: Smaragdi Antonopoulou, et al.
Published: (2003-01-01) -
Azurin a potent anticancer and antimicrobial agent isolated from a novel Pseudomonas aeruginosa strain
by: Nourhan A. Zaghloul, et al.
Published: (2025-01-01) -
Characterization of the De Novo Biosynthetic Enzyme of Platelet Activating Factor, DDT-Insensitive Cholinephosphotransferase, of Human Mesangial Cells
by: Alexandros Basilios Tsoupras, et al.
Published: (2007-01-01) -
Ellagic acid: A potent glyoxalase-I inhibitor with a unique scaffold
by: Al-Shar’i Nizar A., et al.
Published: (2021-03-01)